文献库搜索 | GeneLibs

Fürstenau(M),Niemann(CU),Robrecht(S),Rotba... Blood 2026-06-18

...TP53 aberrations were randomized between 6 cycles of CIT (fludarabine-cyclophosphamide-rituximab [FCR] or bendamustine-r...

Galo(E),Castro(S),Amaral(D),Espada(F),Bran... Horm Res Paediatr 2026-03-30

...TP53 variant as an incidental finding. ICPP incidence in Portuguese boys increased significantly over 2 decades, with ac...

Miao(EA),Yeap(B),Daher(S),Lomibao(M),Sun(F... JCO Precis Oncol 2026-03-00

...TP53 (53% v 25%; P = .026), PDGFRA (16% v 0%; P = .009), KIT (11% v 0%; P = .045), PIK3CA (11% v 0%; P = .045), and MYC ...

Duan(Y),Hashimoto(T),Shibuki(T),Taniguchi(... JCO Precis Oncol 2026-03-00

...TP53 was the most frequent alterations (88.5%), followed by PIK3CA (36.4%), NFE2L2 (24.3%), CCND1 (22.4%), and EGFR (20....

Zhu(Y),Wu(JA),Zhang(D),Chowdhury(S),Wang(H... J Hepatol 2026-08-00

...TP53, CDKN2A, and BAP1, whereas eCCA and GBC exhibited only modest hemispheric differences. We further show that these d...

Gutierrez(C),Kwok(M),Ruthen(N),Waddicor(P)... Nat Commun 2026-03-30

...TP53 deletion, that can overcome this cell cycle block to trigger tumorigenesis.

Yan(Y),Chen(W),Yu(Y),Li(Y),Xiong(W),Zhang(... Leukemia 2026-06-00

...TP53 mutations predicted significantly inferior prognosis in both BTKi-based and non-BTKi cohorts. Our findings indicate...

Zhang(D),Wang(H) Curr Oncol Rep 2026-03-31

...TP53, RB1, and ATRX have been identified through ctDNA analysis, while CTCs, ncRNAs, and EVs provide complementary infor...

Zhang(TJ),Zhao(YJ),Xu(ZJ),Qian(J),Zhou(JD) Am J Hematol 2026-06-00

...TP53 aberrations and FLT3-ITD mutation. Since the IPSS-R and IPSS-M showed a poorly prognostic separation for MDS/AML pa...

Tang(Y),Li(M),Cui(Q),Liu(S),Li(T),Qiu(H),K... J Transl Med 2026-03-30

BACKGROUND: Patients with refractory/relapsed (R/R) B-cell acute lymphoblastic leukemia (B-ALL) harboring TP53 alteratio...